Kiromic BioPharma

$10.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.78 (-7.19%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KRBP and other stocks, options, and ETFs commission-free!

About KRBP

Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX. The listed name for KRBP is Kiromic BioPharma, Inc. Common Stock.

CEO
Maurizio Chiriva-Internati
Employees
Headquarters
Houston, Texas
Founded
2006
Market Cap
50.28M
Price-Earnings Ratio
Dividend Yield
Average Volume
30.71K
High Today
$10.94
Low Today
$9.93
Open Price
$10.90
Volume
46.59K
52 Week High
$18.50
52 Week Low
$8.01

KRBP Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like

SVNDY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure